Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Johnson & Johnson (JNJ)
NYSE:JNJ
Johnson & Johnson (JNJ) Stock Price & Analysis
21,180 Followers
JNJ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$147.91 - $177.11
Previous Close$156.09
Volume9.10M
Average Volume (3M)22.53M
Market Cap
$375.87B
Enterprise Value$394.22B
Total Cash (Recent Filing)$28.50B
Total Debt (Recent Filing)$45.60B
Price to Earnings (P/E)11.6
Beta0.30
Next Earnings
Jan 23, 2024EPS Estimate
$2.48Last Dividend Ex-Date
Aug 25, 2023Dividend Yield
4.64 (3.04%)Share Statistics
EPS (TTM)13.47
Shares Outstanding2,598,969,594
10 Day Avg. Volume6,315,180
30 Day Avg. Volume22,530,494
Standard Deviation0.05
R-Squared0.34
Alpha0.00119
Financial Highlights & Ratios
Price to Book (P/B)-24.65
Price to Sales (P/S)15.89
Price to Cash Flow (P/CF)24.40
P/FCF Ratio30.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.99
Enterprise Value/Gross Profit6.17
Enterprise Value/Ebitda17.20
Forecast
1Y Price Target
$177.14Price Target Upside15.98% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
Johnson & Johnson News
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
JNJ FAQ
What was Johnson & Johnson’s price range in the past 12 months?
Johnson & Johnson lowest stock price was $147.91 and its highest was $177.11 in the past 12 months.
What is Johnson & Johnson’s market cap?
Currently, no data Available
When is Johnson & Johnson’s upcoming earnings report date?
Johnson & Johnson’s upcoming earnings report date is Jan 23, 2024 which is in 96 days.
How were Johnson & Johnson’s earnings last quarter?
Johnson & Johnson released its earnings results on Oct 17, 2023. The company reported $2.66 earnings per share for the quarter, beating the consensus estimate of $2.516 by $0.144.
Is Johnson & Johnson overvalued?
According to Wall Street analysts Johnson & Johnson’s price is currently Undervalued.
Does Johnson & Johnson pay dividends?
Johnson & Johnson pays a Quarterly dividend of $1.19 which represents an annual dividend yield of 2.91%. See more information on Johnson & Johnson dividends here
What is Johnson & Johnson’s EPS estimate?
Johnson & Johnson’s EPS estimate is $2.48.
How many shares outstanding does Johnson & Johnson have?
Johnson & Johnson has 2,408,014,200 shares outstanding.
What happened to Johnson & Johnson’s price movement after its last earnings report?
Johnson & Johnson reported an EPS of $2.66 in its last earnings report, beating expectations of $2.516. Following the earnings report the stock price went down -0.914%.
Which hedge fund is a major shareholder of Johnson & Johnson?
Among the largest hedge funds holding Johnson & Johnson’s share is Fisher Asset Management LLC. It holds Johnson & Johnson’s shares valued at 1B.
---
Johnson & Johnson Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$177.14 (15.98% Upside)
$177.14 (15.98% Upside)
Blogger Sentiment
Bullish
JNJ Sentiment 88%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 726.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $5.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.5%
Last 30 Days ▼ 1.4%
Last 30 Days ▼ 1.4%
News Sentiment
Very Positive
Bullish news 86%
Bearish news 14%
Bearish news 14%
Learn more about TipRanks Smart Score
Company Description
Johnson & Johnson
Johnson & Johnson provides healthcare products across three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
---
Top 5 ETFs holding JNJ
Global X S&P 500 Covered Call ETF
$29.75M
Zacks Earnings Consistent Portfolio ETF
$1.23M
Global X S&P 500 Covered Call & Growth ETF
$624.38K
ClearBridge Dividend Strategy ESG ETF
$581.13K
Global X S&P 500 Tail Risk ETF
$25.79K
Up to five ETFs with an Outperform Smart Score that hold JNJ. The ETFs are listed according to market value of JNJ within the ETF
---